RBIL yields 4.42% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, RBIL + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RBIL + MRK for your $10,000?
RBIL is the first ETF to invest continuously and exclusively in ultra-short, investment grade Treasury inflation-protected securities or TIPS. These income-generating instruments, which are backed by the US Treasury, have interest and principal payments that are adjusted for and can provide a hedge against inflation. TIPS, however, typically have lower yields than conventional fixed-rate bonds. The passively managed fund seeks lower risk and volatility by investing in shorter-term securities instead of longer-duration TIPS that inherently have higher interest rate risk. The portfolio equally weights its sub-components, comprised of bonds with remaining maturities of 1 to 13 months (e.g., 1-2 months, 2-3 months, etc.). The fund may engage in securities lending. The index is rebalanced on the last business day of each month.
Full RBIL Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.